Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Current Opinion in Rheumatology|May 26, 2010
Measuring and improving adherence to osteoporosis pharmacotherapySuzanne M Cadarette, Andrea M BurdenJBI Evidence Synthesis|October 12, 2021
Fracture outcome definitions in observational osteoporosis drug effects studies: a scoping review protocolNatalia Konstantelos, Anna M Rzepka, Suzanne M CadaretteTherapeutic Advances in Chronic Disease|January 28, 2012
Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendationsMilica Nikitovic, Daniel H Solomon, Suzanne M CadaretteCurrent Opinion in Rheumatology|May 5, 2009
Osteoporosis treatments and adverse eventsDaniel H Solomon, Laura Rekedal, Suzanne M CadaretteBone Reports|December 25, 2023
Methodological guidance for the use of real-world data to measure exposure and utilization patterns of osteoporosis medicationsKaleen N Hayes, Suzanne M Cadarette, Andrea M BurdenJBI Evidence Synthesis|May 31, 2021
Observational study methods used to assess pharmacotherapy effects of type 2 diabetes on fracture risk: a scoping review protocolKaleen N Hayes, Anisha K Hundal, Suzanne M CadaretteThe Journal of Rheumatology|March 3, 2005
Fracture prevalence and treatment with bone-sparing agents: are there urban-rural differences? A population based study in Ontario, CanadaSuzanne M Cadarette, Susan B Jaglal, Gillian A HawkerJournal of Clinical Epidemiology|May 6, 2004
Osteoporosis health belief scale: minor changes were required after telephone administration among womenSuzanne M Cadarette, Dorcas E Beaton, Gillian A HawkerArchives of Osteoporosis|February 10, 2016
Urban-rural differences in the uptake of new oral bisphosphonate formulationsRacquel Jandoc, Muhammad Mamdani, Linda E Lévesque, et al.Pharmacoepidemiology and Drug Safety|November 23, 2012
Disease risk score as a confounder summary method: systematic review and recommendationsMina Tadrous, Joshua J Gagne, Til Stürmer, et al.Pageof 9